The BioPharm International® editors present our most popular technical articles from 2024.
BioPharm International® publishes independent, science-based articles and peer-reviewed papers from biopharmaceutical professionals working in the development and manufacturing of biologics. In 2024, BioPharm International®, via print issues, ebooks, and our website, BioPharmInternational.com, published articles on topics ranging from cell and gene therapies, viral clearance, fill/finish, aseptic processing, and more.
The following are our picks for the ‘best of’ technical and peer-reviewed articles published in 2024, in no particular order:
For more peer-reviewed articles, please visit https://www.biopharminternational.com/topic/peer-reviewed-research.
For the latest on drug development, please visit https://www.biopharminternational.com/topic/development.
To read in-depth upstream processing articles, visit https://www.biopharminternational.com/topic/upstream.
A variety of quality-related topics can be found at https://www.biopharminternational.com/topic/quality. And the latest manufacturing technologies are discussed at https://www.biopharminternational.com/topic/manufacturing.
For information on how to submit technical and peer-reviewed articles to BioPharm International®, please view our submission guidelines at https://www.biopharminternational.com/view/editorial-information.
FDA Reopens Comment Period on HCP Immunogenicity Risk of Follow-on Recombinant Peptides
January 2nd 2025FDA is reopening the comment period for the Federal Register Notice, “Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant Peptide Products: Establishment of a Public Docket: Request for Information and Comments”, until March 3, 2025.